首页> 外文期刊>Nature >Japan's Gatekeeper of Medical Products
【24h】

Japan's Gatekeeper of Medical Products

机译:日本医疗产品关门人

获取原文
获取原文并翻译 | 示例
           

摘要

Regulating the constant stream of new and innovative pharmaceuticals and medical devices to ensure that the safety of the public is protected is a challenging and evolving process. Japan's Pharmaceuticals and Medical Devices Agency (PMDA), in line with the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), was established as an independ- with the safety of Japanese citizens as an immovable central priority. The services conducted by the PMDA are undertaken with equity, transparency and the highest ethical standards. Since the foundation of the organization, the PMDA has grown three-fold in size and undertaken a range of initiatives that have halved the length of the review period for new pharmaceuticals.
机译:不断调节新的创新药物和医疗设备以确保公众安全受到保护是一个充满挑战和不断发展的过程。日本药品和医疗器械局(PMDA)与美国食品药品管理局(FDA)和欧洲药品局(EMA)成立,是独立的,将日本公民的安全作为不可或缺的中心任务。 PMDA提供的服务是公平,透明和最高道德标准的。自该组织成立以来,PMDA的规模已增长了三倍,并采取了一系列措施,将新药的审查期缩短了一半。

著录项

  • 来源
    《Nature》 |2014年第7498期|A2-A2|共1页
  • 作者

  • 作者单位
  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号